Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expedia Group Inc (EXPE) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Expedia Group IncTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Expedia Group Inc vs Intuitive Surgical, Inc. — how do they compare? Expedia Group Inc trades at $274.22 (market cap $32.42B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 4.5× Expedia Group Inc's market cap, and Expedia Group Inc pays a 0.71% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expedia Group Inc for 47 Days and Intuitive Surgical, Inc. for 84 Days on average.

EXPEISRG
Market Cap
$32.42B$146.76B
Volume
1,940,6712,529,814
Sector
Consumer CyclicalHealth
52-Week High
$339.13$592.85
52-Week Low
$188.51$332.02
Typical Hold Time
47 Days84 Days
Enterprise Value
$30.98B$141.54B
Dividend Yield
0.71%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expedia Group Inc

Expedia Group (EXPE) trades at $270.13, up 4.35% today, with a bullish technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.76 surpassing the $5.22 forecast. Revenue growth is steady, reaching $14.73 billion in 2025, and the company maintains a high gross profit margin of 90.43%. However, recent news highlights competitive threats from AI agents, and the stock faces resistance near $275.

The outlook for EXPE is mixed; solid earnings growth and a consensus price target of $335.06 suggest upside potential, but investor sentiment is cautious due to AI disruption risks and a nearly even split between buy and hold ratings. Key risks include Meta's Muse AI agent potentially bypassing travel aggregators and ongoing layoffs impacting operational efficiency.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.

ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXPE
77% Buy23% Sell
Avg holding period · 47 Days
ISRG
92% Buy8% Sell
Avg holding period · 84 Days

Top news

Latest headlines on both assets

About Expedia Group Inc

Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

Read more on EXPE →

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →